Tivantinib (ARQ197) in hepatocellular carcinoma.
Porta C, Giglione P, Ferrari A, Reversi F, Liguigli W, Imarisio I, Ganini C.
Porta C, et al. Among authors: liguigli w.
Expert Rev Anticancer Ther. 2015 Jun;15(6):615-22. doi: 10.1586/14737140.2015.1050383.
Expert Rev Anticancer Ther. 2015.
PMID: 26035719
Review.